Global In Vitro Lung Model Market Overview:
Global In Vitro Lung Model Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global In Vitro Lung Model Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of In Vitro Lung Model involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the In Vitro Lung Model Market:
The In Vitro Lung Model Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for In Vitro Lung Model Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study In Vitro Lung Model Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, In Vitro Lung Model market has been segmented into:
2D Model
3D Model
By Application, In Vitro Lung Model market has been segmented into:
Drug Discovery & Toxicology Studies
Physiological Research
3D Model Development
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The In Vitro Lung Model market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the In Vitro Lung Model market.
Top Key Players Covered in In Vitro Lung Model market are:
Epithelix
MATTEK
Lonza
Emulate
AlveoliX AG
Nortis
CN Bio Innovations Ltd
MIMETAS
InSphero
ATTC
Tissuse GmbH and Cn Bio Innovations Limited
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: In Vitro Lung Model Market by Type
4.1 In Vitro Lung Model Market Snapshot and Growth Engine
4.2 In Vitro Lung Model Market Overview
4.3 2D Model
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 2D Model: Geographic Segmentation Analysis
4.4 3D Model
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 3D Model: Geographic Segmentation Analysis
Chapter 5: In Vitro Lung Model Market by Application
5.1 In Vitro Lung Model Market Snapshot and Growth Engine
5.2 In Vitro Lung Model Market Overview
5.3 Drug Discovery & Toxicology Studies
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Drug Discovery & Toxicology Studies: Geographic Segmentation Analysis
5.4 Physiological Research
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Physiological Research: Geographic Segmentation Analysis
5.5 3D Model Development
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 3D Model Development: Geographic Segmentation Analysis
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 In Vitro Lung Model Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 EPITHELIX
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 MATTEK
6.4 LONZA
6.5 EMULATE
6.6 ALVEOLIX AG
6.7 NORTIS
6.8 CN BIO INNOVATIONS LTD
6.9 MIMETAS
6.10 INSPHERO
6.11 ATTC
6.12 TISSUSE GMBH AND CN BIO INNOVATIONS LIMITED
Chapter 7: Global In Vitro Lung Model Market By Region
7.1 Overview
7.2. North America In Vitro Lung Model Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 2D Model
7.2.4.2 3D Model
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Drug Discovery & Toxicology Studies
7.2.5.2 Physiological Research
7.2.5.3 3D Model Development
7.2.5.4 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe In Vitro Lung Model Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 2D Model
7.3.4.2 3D Model
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Drug Discovery & Toxicology Studies
7.3.5.2 Physiological Research
7.3.5.3 3D Model Development
7.3.5.4 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe In Vitro Lung Model Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 2D Model
7.4.4.2 3D Model
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Drug Discovery & Toxicology Studies
7.4.5.2 Physiological Research
7.4.5.3 3D Model Development
7.4.5.4 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific In Vitro Lung Model Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 2D Model
7.5.4.2 3D Model
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Drug Discovery & Toxicology Studies
7.5.5.2 Physiological Research
7.5.5.3 3D Model Development
7.5.5.4 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa In Vitro Lung Model Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 2D Model
7.6.4.2 3D Model
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Drug Discovery & Toxicology Studies
7.6.5.2 Physiological Research
7.6.5.3 3D Model Development
7.6.5.4 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America In Vitro Lung Model Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 2D Model
7.7.4.2 3D Model
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Drug Discovery & Toxicology Studies
7.7.5.2 Physiological Research
7.7.5.3 3D Model Development
7.7.5.4 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
In Vitro Lung Model Scope:
|
Report Data
|
In Vitro Lung Model Market
|
|
In Vitro Lung Model Market Size in 2025
|
USD XX million
|
|
In Vitro Lung Model CAGR 2025 - 2032
|
XX%
|
|
In Vitro Lung Model Base Year
|
2024
|
|
In Vitro Lung Model Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd, MIMETAS, InSphero, ATTC , Tissuse GmbH and Cn Bio Innovations Limited.
|
|
Key Segments
|
By Type
2D Model
3D Model
By Applications
Drug Discovery & Toxicology Studies
Physiological Research
3D Model Development
Others
|
